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We previously identiﬁed hepatoma-derived growth factor-related protein-3 (HRP-3) as a radioresistant
biomarker in p53 wild-type A549 cells and found that p53-dependent induction of the PUMA pathway
was a critical event in regulating the radioresistant phenotype. Here, we found that HRP-3 knockdown
regulates the radioresistance of p53-null H1299 cells through a distinctly different molecular mechanism.
HRP-3 depletion was sufﬁcient to cause apoptosis of H1299 cells by generating substantial levels of reac-
tive oxygen species (ROS) through inhibition of the Nrf2/HO-1 antioxidant pathway. Subsequent, ROS-
dependent and p53-independent NF-jB activation stimulated expression of c-Myc and Noxa proteins,
thereby inducing the apoptotic machinery. Our results thus extend the range of targets for the develop-
ment of new drugs to treat both p53 wild-type or p53-null radioresistant lung cancer cells.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Hepatoma-derived growth factor (HDGF) is the original mem-
ber of a family of polypeptides designated HDGF-related proteins
(HRPs). The HRP family consists of ﬁve proteins, which share a
HATH domain at a well-conserved region of the N-terminus [1].
Very little is currently known regarding the function of the differ-
ent HRP family members. HRP-1 exhibits testis-speciﬁc expression
in mice and may play a pivotal role in the cell cycle phase around
meiotic cell division during spermatogenesis [2]. HRP-2 inﬂuences
several biological functions, including chromatin remodeling, DNA
repair and ribosome biogenesis [3]. HRP-4 and lens epithelium-
derived growth factor (LEDGF) have been conﬁrmed to exhibit
mitogenic activity in ﬁbroblasts [1] and lens epithelial cells [4],
respectively. LEDGF has been shown to function as a transcrip-
tional activator and to potentiate the activity of human immuno-
deﬁciency virus integrase [5]. HRP-3 protein is expressed mainly
in the testis and brain and to a lesser degree in the heart, ovaries,
kidneys, spleen, and liver in humans [6]. Since HRP-3 in humansand mice contains a putative nuclear localization signal sequence
in the self-speciﬁc region, it may function predominantly in the
nucleus of cells in the brain and testis to play a role in cell prolif-
eration. Consistent with this, overexpression of HRP-3 in human
embryonic kidney cells has been shown to promote proliferative
activity, whereas HRP-3 depletion in mantle cell lymphoma leads
to proliferative arrest [7]. HRP-3 also plays a pivotal role during
mouse embryonic neuronal development by interacting with the
tubulin component of the neuronal cytoskeleton [8]. Because
HRP-3 is expressed in both proliferative and differentiated cells
of the brain, it might not be restricted to acting as a mitogenic fac-
tor [9]. The functional association of HRP-3 with tumor progression
has been demonstrated in hepatocellular carcinoma (HCC) cells
[10]. These studies showed that HRP-3 protected HCC cells from
anoikis through a mechanism that was critically dependent on
extracellular-signal-regulated kinase. We previously reported that
HRP-3 acted through a signaling cascade involving regulation of
reactive oxygen species (ROS)-dependent p53 activation and sub-
sequent p53-dependent induction of PUMA (p53 upregulated
modulator of apoptosis) expression to play an essential role in reg-
ulating the phenotype of p53 wild-type A549 cells [11]. However,
the role and molecular mechanism of HRP-3 action in p53-null
non-small-cell lung carcinoma (NSCLC) H1299 cells has remained
completely unknown.
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sensitizes H1299 cells to the induction of apoptotic cell death. Sim-
ilar to the case in A549 cells, increased ROS generation through
inhibition of nuclear factor erythroid 2 related factor 2 (Nrf2)/heme
oxygenase 1 (HO-1) was a critical event during the apoptotic pro-
cess in HRP-3-knockdown H1299 cells. However, in H1299 cells,
unlike A549 cells, ROS induced nuclear factor-kappa B (NF-jB)
activity, which acted as an upstream signal in the c-Myc and Noxa
apoptotic pathway. Thus, we suggest that enhancement of the
p53-independent ROS/NF-jB/c-Myc/Noxa cascade by HRP-3
knockdown plays an important role in promoting apoptosis in
radioresistant, p53-null H1299 cells.
2. Materials and methods
2.1. Cell culture and treatment
Human lung cancer cell lines (H1299, A549, and H460), cervical
cancer cell lines (SiHa and HeLa), colon cancer cell lines (HCT-8 and
HCT 116), and breast cancer cell lines (MCF-7 and MDA-MB-231)
were purchased from the ATCC (Manassas, VA, USA). H1299,
A549, H460, MCF-7, HCT-8 and HCT 116 cells were cultured in
RPMI-1640 medium, and MDA-MB-231, SiHa and HeLa cells were
cultured in DMEMmedium. In all cases, media were supplemented
with 10% fetal bovine serum. Cells were irradiated using a 137Cs-
ray source (Atomic Energy of Canada, Ltd., Mississauga, Canada)
or treated with doxorubicin or vinblastine (Sigma, St. Louis, MO,
USA) to induce apoptosis [11]. N-acetyl cysteine (NAC; Sigma)
was used to scavenge ROS, and BAY 11-7082 (Calbiochem, San
Diego, CA, USA) was used to block NF-jB activation [12].
2.2. Cell proliferation
Cells, with and without HRP-3 knockdown, were plated on cul-
ture dishes at a density of 3.5  105 cells/cm2 and incubated for the
indicated times. Cell proliferation was determined by directly
counting surviving cells using a hemocytometer.
2.3. Assay for cell death
Cell death was quantiﬁed as described previously [12].
2.4. Oncomine data mining
Oncomine™ (Life Technologies, Ann Arbor, MI, USA) was used
for data analysis and visualization. Datasets from the Oncomine
cancer microarray database (https://www.oncomine.com/
resource/main.html) were selected for use in determining changes
in HRP-3 mRNA expression and DNA copy number. These datasets
provide fold-change values of gene expression and statistical sig-
niﬁcance (determined by P-values) involving comparisons
between cancer and normal samples or between different cancers,
as well as gene expression changes related to clinical-pathological
characteristics of patients. HRP-3 expression was compared in lung
cancer and normal lung tissue extracts.
2.5. ROS assay
Cells were incubated with 10 nM 20,70-dichloroﬂuorescein diac-
etate (DCF-DA; Molecular Probes, Inc., Eugene, OR, USA) for 20 min
to detect ROS, as described previously [12].
2.6. Quantitative real-time polymerase chain reaction (PCR)
HRP-3 mRNA levels were determined by quantitative real-time
PCR using a Chromo 4 Cycler and SYBR Premix Ex Taq (Takara Bio,Shiga, Japan). Protocols and primer pairs used were as described
previously [11], and reactions were preformed in triplicate.
2.7. Knockdown of HRP-3 by small interfering RNA (siRNA)
Cells were transfected with HRP-3 siRNA as described
previously [11].
2.8. Western blot analysis
Western blot analyses were done as described previously [13]
using primary antibodies against HRP-3 (Proteintech Group, Inc.,
Chicago, IL, USA); p53, Nrf2, Bcl-2, Bcl-xl, Bax, and Ij-B (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA); Keap1 (R&D Systems, Inc.,
Minneapolis, MN, USA); cleaved-PARP (Asp214), cleaved caspase-
3, phospho-p53 (Ser15), PUMA, and HO-1 (Cell Signaling Technol-
ogy Inc., Beverly, MA, USA); and c-Myc and Noxa (Calbiochem, San
Diego, CA, USA). b-Actin (Sigma) was used as a loading control.
2.9. Immunoﬂuorescence confocal microscopy
Immunoﬂuorescence staining for HRP-3 was performed as
described previously [11].
2.10. Reporter gene assay
Cells were transfected with 0.5 lg plasmid DNA (pNF-jB-luc;
Stratagene, Cambridge, UK) under the indicated experimental con-
ditions using the Superfect transfection reagent (Qiagen, Crawley,
UK), as described by the manufacturer. The cells were harvested
and prepared for Dual-Reporter Luciferase Assays (Promega,
Southampton, UK) according to the manufacturer’s protocol. NF-
jB transcriptional activity was quantiﬁed in triplicate using a
luminometer and was normalized to the protein concentrations
of the samples. NF-jB activity was also determined indirectly by
analyzing the degradation of I-jB using Western blot analysis.
2.11. Statistical analysis
Cell culture experiments were repeated at least three times.
Statistical differences between groups were assessed by Students
t-test, and a p-value <0.05 was considered signiﬁcant.
3. Results
3.1. Association of HRP-3 with the resistance phenotype of p53-null
H1299 cells
We ﬁrst examined the correlation between HRP-3 gene expres-
sion and lung cancer severity using the human genetic dataset
analysis tool, Oncomine. As shown in Fig. 1A, HRP-3 mRNA levels
were signiﬁcantly higher in lung carcinoid tumors and small-cell
lung carcinoma, marginally different in lung adenocarcinoma,
and not different in squamous cell lung carcinoma compared to
normal lung cells, demonstrating that increased expression of
HRP-3 is correlated with increased tumorigenesis. In our previous
report, we explored the role of HRP-3 as a radioresistance-related
gene in p53 wild-type A549 cells [11]. To examine HRP-3 function
in p53-null NSCLC H1299 cells, which are also radioresistant, we
compared HRP-3 expression levels among lung cancer cells. Con-
sistent with results obtained in A549 cells, HRP-3 transcript
(Fig. 1B, top) and protein (Fig. 1B, bottom) levels were much higher
in H1299 cells than in H460 cells, supporting the p53-independent
association of HRP-3 with the radioresistance phenotype. HRP-3
protein was localized only in the nucleus of H1299 cells, consistent
HRP-3 
β-actin
H
460
H
1299
B A 
A549
H
12
99
HRP-3 DAPI Merge
H
46
0
C 
0     12     24    36    48   (h)    
HRP-3 
β-actin
HRP-3 
β-actin
HRP-3 
β-actin
D
ox
or
ub
ic
in
Vi
nb
la
st
in
e
R
ad
ia
tio
n
D 
H
R
P -
3 
D
AP
I
Radiation (10 Gy) 
0 h               24 h
E 
HRP-3 
Doxorubicin (0.1 μg) Vinblastine (5 ng) 
0 h              12h
M
er
ge
2.5
2.0
1.5
1.0
0.5
0 
H
R
P-
3 
m
R
N
A
**
* 
0 h              12h
Fig. 1. HRP-3 is associated with the resistant phenotype of p53-null H1299 cells. (A) Available datasets in the Oncomine database were queried for HRP-3 expression with
respect to cancer versus normal (threshold p-value = 1  104; fold changeP2). 0, no value; 1, lung adenocarcinoma; 2, lung carcinoid tumor; 3, small cell lung carcinoma; 4,
squamous cell carcinoma. (B) Transcript and protein levels of HRP-3 in lung cancer cells were determined by quantitative real-time PCR (top) and Western blotting (bottom),
respectively. (C) Representative confocal images of HRP-3 localization in H460 and H1299 cells. Scale bar: 50 lm. (D and E) H1299 cells were treated with 10 Gy radiation,
0.1 lg/mL doxorubicin, or 5 ng/mL vinblastine for the indicated times. HRP-3 protein level and localization were determined by Western blotting (D) and laser scanning
confocal microscopy (E), respectively. Scale bar: 50 lm.
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(Fig. 1C). We next determined whether HRP-3 mediates responses
to radiation or anti-cancer drugs, such as doxorubicin or vinblas-
tine, in H1299 cells. HRP-3 protein levels were increased by all
stimuli, reaching a peak at about 12–24 h (depending on the stress)
and then declining to basal levels (Fig. 1D), implicating HRP-3 as a
radiation- and drug-responsive protein. Although the subcellular
localization of HRP-3 changed rapidly from nucleus to cytoplasm
in SMMC-7721 cells exposed to epidermal growth factor [10], its
localization was unchanged by radiation or anti-cancer drugs in
H1299 cells (Fig. 1E). Taken together, our data suggest that the
radiation-responsive HRP-3 protein acts through a nuclear signal
transduction mechanism to play a role in maintaining the resis-
tance phenotype of p53-deﬁcient H1299 cells.
3.2. HRP-3 depletion synergizes with radiation to induce enhanced
apoptosis in a cell-type dependent manner
Apoptotic stimuli marginally induced cell death in H1299 cells
(approximately 20%, 23%, and 26% for radiation, doxorubicin, and
vinblastine, respectively) and markedly induced cell death in
H460 cells (approximately 41%, 39%, and 43%, respectively)
(Fig. 2A), demonstrating that H1299 cells possess a resistance phe-
notype compared with H460 cells. To determine whether HRP-3 is
associated with the tolerance of H1299 cells, we depleted endoge-
nous HRP-3 using siRNA. HRP-3 depletion in H1299 cells strongly
reduced cell proliferation in a time-dependent fashion (Fig. 2B)
and elevated the levels of cleaved PARP and active caspase-3
(Fig. 2C) compared to control cells. To better understand the func-
tion of HRP-3 in the resistance phenotype, we analyzed the effect
of HRP-3 loss-of-function in H1299 cells treated with the same
stimuli as shown in Fig. 2A. Whereas transfection of H1299 cells
with siHRP-3 alone induced approximately 21% cell deathcompared to 10% in controls, co-stimulation of siHRP-3-transfected
cells with radiation, doxorubicin, or vinblastine promoted cell
death by approximately 42%, 45%, and 47%, respectively (Fig. 2D),
indicating that HRP-3 knockdown enhances the cell death sensitiv-
ity of H1299 cells. To examine whether the correlation between
HRP-3 and radiosensitivity is universal, we stimulated other cancer
cell lines with siHRP-3 alone or in combination with radiation.
Although siHRP-3 alone induced apoptosis to different degrees in
SiHa, HCT-8 and MCF-7 cells, combined stimulation with radiation
resulted in synergistic induction of apoptosis (Fig. 2E). siHRP-3
alone did not induced apoptosis in HeLa or MDA-MB-231 cells
and did not synergize with radiation in these cells (Fig. 2E). There-
fore, our results suggest that the contribution of HRP-3 to the reg-
ulation of radiosensitivity is cell-type dependent.
3.3. Depletion of HRP-3 induces apoptosis of H1299 cells via ROS
generation, independent of PUMA and Bax signaling pathways
Consistent with the result presented in section 3.2, both cleaved
PARP and active caspase-3 levels were signiﬁcantly increased by
HRP-3 knockdown, alone or in combination with radiation, com-
pared to control cells (Fig. 3B). These patterns of apoptotic markers
were paralleled with morphological changes characteristic of
apoptosis (Fig. 3A, left) and an increased cell death rate (Fig. 3A,
right). To identify the mechanisms by which HRP-3 depletion
induces cytotoxicity in H1299 cells, we focused on the transcrip-
tion factor Nrf2 and its target HO-1 antioxidant coordinators
involved in regulating ROS production. Knockdown of HRP-3
expression in H1299 cells resulted in a marked reduction in Nrf2
and HO-1 protein levels without any change in the expression of
Keap-1, a repressor of Nrf2 activation (Fig. 3C), suggesting that a
p53-independent Nrf2/HO-1 signaling mechanism, as a down-
stream target of HRP-3, is responsible for the induction of ROS.
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Fig. 2. Synergistic effects of HRP-3 depletion and treatment with radiation or anti-cancer drugs on cytotoxicity toward H1299 cells. (A) H460 and H1299 cells were treated as
in Fig. 1E for 48 h. Cell death was determined by FACS analysis, and data are expressed as means ± SD (⁄⁄p < 0.005 and ⁄⁄⁄p < 0.0005 compared with untreated controls). (B and
C) H1299 cells were transfected with 100 nM scrambled or HRP-3 siRNA for 5 h and then cultured for an additional 4 d (B) or 2 d (C). Proliferation was determined by cell
counting, and data are expressed as means ± SD (⁄p < 0.05 and ⁄⁄p < 0.005 compared with controls) (B) and protein levels of two apoptosis markers were determined by
Western blotting (C). (D) H1299 cells were transfected with 100 nM scrambled or HRP-3 siRNA and then treated as in Fig. 1E for 48 h. Cell death was determined by FACS
analysis, and data are expressed as means ± SD (⁄⁄p < 0.005 compared with cells treated with siHRP-3 only). (E) Cells were transfected with 100 nM scrambled or HRP-3 siRNA
and then treated without or with 10 Gy radiation for 48 h. FACS analysis data are expressed as means ± SD (⁄p < 0.05 and ⁄⁄p < 0.05 compared with cells treated with radiation
alone; x, not signiﬁcant).
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Fig. 3. HRP-3 knockdown-induced apoptosis is associated with ROS generation, but not Bax family modulation, in H1299 cells. (A and B) H1299 cells were stimulated as in
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microscopy (D, left; scale bar, 1 mm), and ROS production was assessed by FACS analysis of DCF-DA-stained cells (D, right). Data are expressed as means ± SD (⁄⁄p < 0.05
compared with controls). (E) H1299 cells were transfected as in C. Levels of cell death-related proteins were determined by Western blotting.
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ference alone or in combination with radiation markedly induced
ROS generation in H1299 cells (Fig. 3D, left). In siHRP-3-treated
H1299 cells exposed to radiation, ROS was induced by approxi-
mately 2.8-fold compared to control cells. This induction was
reduced to normal values by the ROS scavenger NAC (Fig. 3D,
right), demonstrating that HRP-3 plays a pivotal role in the regula-
tion of ROS independent of p53. We previously reported that the
p53 and Bcl-2 family proteins, Bax and Bcl-2, as well as PUMA
acted as downstream signaling effectors of ROS to induce apoptosis
of A549 cells [11,12]. However, none of these signal transduction
pathways were involved in H1299 cell death induced by HRP-3
interference (Fig. 3E), conﬁrming the association of ROS-dependent
and p53-independent mechanisms with other signaling pathways.3.4. ROS-dependent NF-jB activation and c-Myc/Noxa expression are
essential for siHRP-3-induced apoptosis of H1299 cells
To dissect the effectors involved in regulating HRP-3 depletion-
induced apoptosis, we focused on activation of NF-jB, a transcrip-
tion factor activated by oxidant mechanisms [12]. Transfection of
H1299 cells with siHRP-3 led to degradation of Ij-B protein
(Fig. 4A, left) and this phenomenon was associated with an
increase (1.8-fold) in NF-jB activity compared to control cells
(Fig. 4A, right). These ﬁndings are supported by the observed
increases in the expression of c-Myc, a transcriptional target of
NF-jB, and Noxa, a transcriptional target of c-Myc (Fig. 4A, left).
To more ﬁrmly establish the apoptotic role of NF-jB in H1299 cells,
we monitored changes in NF-jB after treating HRP-3-silenced cells
with radiation. Although treatment of H1299 cells with radiation
alone caused degradation of Ij-B and induction of c-Myc/Noxa
expression compared to control cells, these phenomena were
enhanced in HRP-3-knockdown H1299 cells treated with radiation
(Fig. 4B, left). Speciﬁcally, whereas radiation alone increased NF-jBA 
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alone in C and D).activity by approximately 1.8-fold, it increased NF-jB by 3.1-fold
in HRP-3-depleted H1299 cells (Fig. 4B, right). As shown in
Fig. 4C, Ij-B degradation and NF-jB activation induced by siHRP-
3 were completely restored to control levels by scavenging ROS
with NAC. Consistent with this, NAC dramatically attenuated the
increase in c-Myc and Noxa levels induced in H1299 cells by trans-
fection of siHRP-3 (Fig. 4C, left). Finally, we conﬁrmed that accu-
mulation of c-Myc and Noxa proteins was due to NF-jB using
the inhibitor of NF-jB activation, BAY 11-7082 (BAY). As expected,
treatment of H1299 cells with BAY blocked siHRP-3-induced Ij-B
degradation (Fig. 4D, left) and NF-jB activation (Fig. 4D, right). In
line with these results, the expression of c-Myc and Noxa proteins,
which were highly induced by siHRP-3, were down-regulated by
BAY in parallel with the decrease in NF-jB activity (Fig. 4D, left).
These results demonstrate that ROS-induced NF-jB activity
contributes to the apoptotic commitment of H1299 cells through
a cascade involving the NF-jB downstream targets, c-Myc and
Noxa.4. Discussion
The tumor suppressor gene p53 is frequently somatically
mutated or deleted in various human NSCLC cells, and this status
usually leads to elevated cellular resistance to anticancer drugs
or radiation. In keeping with this, A549 and H460 cells carrying
wild-type copies of p53 are more sensitive to resveratrol-induced
apoptosis than p53-deﬁcient H1299 cells [14]. In the present study,
H460 cells also showed greater sensitivity to anti-cancer drugs and
radiation than H1299 cells. Because combining radiotherapy with
gene therapy may be an effective strategy for treating resistant
lung cancers, understanding the molecular mechanisms responsi-
ble for radiosensitivity could prove very helpful in improving can-
cer treatment. In our previous report, we found that depletion of
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through upregulation of p53-dependent PUMA expression [11].
However, HRP-3 functions and apoptotic signaling pathways in
p53-null lung cancer cells have remained unknown.
Here, we demonstrated that HRP-3 knockdown strongly pro-
moted cell death in H1299 cells via an ROS-dependent apoptotic
process. The mechanism of ROS induction in H1299 cells, which
included a marked decrease in the antioxidant enzyme HO-1,
was completely consistent with the results obtained in A549 cells
(Fig. 3), indicating that HRP-3 depletion promotes ROS induction
through both p53-dependent (A549) and -independent (H1299)
mechanisms. Although radiation is used extensively to treat cancer
and has been shown to generate ROS in a variety of cells [13], we
found that the synergistic effects of combined therapy with
siHRP-3 was cell-type dependent. Notably, we found that HRP-3-
knockdown H1299 cells exhibited enhanced activation of NF-jB
(Fig. 4), which has dual functions as an inhibitor or activator of
apoptosis according to circumstances [15]. Although several lines
of evidence point to NF-jB subunits being recruited to the p53
pathway, our observation that inhibition of ROS generation sup-
pressed siHRP-3-induced NF-jB activation suggests that NF-jB
activation in p53-deﬁcient H1299 cells is ROS dependent. Thus,
NF-jB activation is capable of serving a pro-apoptotic function in
H1299 cells, as amply illustrated in a recent review [15]. Although
we previously established that ROS is an upstream signaling ele-
ment in HRP-3-depleted A549 cells that acted through the p53/
PUMA cascade to promote apoptosis, we found that the PUMA
pathway was not involved in the siHRP-3-mediated apoptosis of
H1299 cells. Moreover, the linkage of mitochondrial dysfunction
to the NF-jB pathway targets Bax and Bcl-2 and subsequent
release of cytochrome c from mitochondria- key aspects of cell
death in HRP-3-knockdown A549 cells [12]-were also not involved
in siHRP-3-induced apoptosis in H1299 cells (Fig. 3). Notably, we
found that HRP-3 depletion induced an increase in the protein lev-
els of the transcription factor c-Myc and the pro-apoptotic Noxa in
H1299 cells. In contrast to the function of c-Myc as a promoter of
cancer cell growth and survival, we found here that c-Myc partic-
ipated in the apoptotic response. Generally, sensitization to or
triggering of apoptosis by c-Myc can be either p53-dependent or
p53-independent, depending on the cell type and apoptotic trigger
[16]. Our results provide additional evidence for the association of
p53-independent, c-Myc-activated apoptosis in a lung cancer cell
type. Increased expression of Noxa by p53 is also fundamentally
important, causing apoptosis predominantly by triggering cyto-
chrome c release from mitochondria into the cytosol [16].
Although the genes for c-Myc and Noxa are known to be targets
of p53, both proteins played a pivotal role in amplifying the apop-
totic pathway in p53-deﬁcient H1299 cells. Thus, our data strongly
suggest that c-Myc is a target of activated NF-jB in siHRP-3-trans-
fected H1299 cells, and the subsequent increase in c-Myc expres-
sion may directly induce Noxa gene expression to induce
cytotoxicity. These ﬁndings are fully consistent with the p53-inde-
pendent and c-Myc-dependent transactivation of the Noxa pro-
moter observed in melanoma cancer cells stimulated with the
anticancer agent bortezomib [17].
In conclusion, NF-jB activation is required for the siHRP-3-
induced signaling pathways upstream of c-Myc and Noxa in the
absence of functional p53. In addition, siHRP-3 can mediate both
p53-dependent and -independent apoptotic signals and intersects
with the radiation-response pathway in a cell-type dependent
manner. Therefore, our results suggest that the application ofHRP-3 knockdown, in combination with other methods of radio-
therapy or chemotherapy, is a promising new therapeutic strategy
for the treatment of both p53 wild-type and p53-null lung cancers.
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